Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 ND-007
1.2.3 Foralumab
1.2.4 Coltelizumab
1.2.5 AVA-002
1.2.6 Others
1.3 Market by Application
1.3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Autoimmune Disorders
1.3.3 Hepatitis B
1.3.4 Multiple Sclerosis
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2018-2034)
2.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2018-2023)
2.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 T Cell Surface Glycoprotein CD3 Epsilon Chain Countries Ranking by Market Size
3 T Cell Surface Glycoprotein CD3 Epsilon Chain Competitive by Company
3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Players
3.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Players (2018-2023)
3.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Players (2018-2023)
3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue
3.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Ratio
3.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in 2024
3.5 Global Key Players of T Cell Surface Glycoprotein CD3 Epsilon Chain Head office and Area Served
3.6 Global Key Players of T Cell Surface Glycoprotein CD3 Epsilon Chain, Product and Application
3.7 Global Key Players of T Cell Surface Glycoprotein CD3 Epsilon Chain, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Breakdown Data by Type
4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Revenue by Type (2018-2023)
4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Revenue by Type (2024-2034)
5 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Breakdown Data by Application
5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Market Size by Application (2018-2023)
5.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023)
6.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2034)
6.3 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2034)
6.4 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023)
7.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2034)
7.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2034)
7.4 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023)
8.2 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2034)
8.3 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2034)
8.4 Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023)
9.2 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2034)
9.3 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2034)
9.4 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023)
10.2 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2034)
10.3 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2034)
10.4 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.1.4 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.1.5 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.1.6 Amgen Inc Recent Development
11.2 Celgene Corp
11.2.1 Celgene Corp Company Details
11.2.2 Celgene Corp Business Overview
11.2.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.2.4 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.2.5 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.2.6 Celgene Corp Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.3.4 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.3.6 F. Hoffmann-La Roche Ltd Recent Development
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Details
11.4.2 GlaxoSmithKline Plc Business Overview
11.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.4.4 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.4.5 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.4.6 GlaxoSmithKline Plc Recent Development
11.5 MacroGenics Inc
11.5.1 MacroGenics Inc Company Details
11.5.2 MacroGenics Inc Business Overview
11.5.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.5.4 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.5.5 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.5.6 MacroGenics Inc Recent Development
11.6 Meridigen Biotech Co Ltd
11.6.1 Meridigen Biotech Co Ltd Company Details
11.6.2 Meridigen Biotech Co Ltd Business Overview
11.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.6.4 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.6.5 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.6.6 Meridigen Biotech Co Ltd Recent Development
11.7 Numab Innovation AG
11.7.1 Numab Innovation AG Company Details
11.7.2 Numab Innovation AG Business Overview
11.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.7.4 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.7.5 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.7.6 Numab Innovation AG Recent Development
11.8 SYNIMMUNE GmbH
11.8.1 SYNIMMUNE GmbH Company Details
11.8.2 SYNIMMUNE GmbH Business Overview
11.8.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.8.4 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.8.5 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.8.6 SYNIMMUNE GmbH Recent Development
11.9 Tiziana Life Sciences Plc
11.9.1 Tiziana Life Sciences Plc Company Details
11.9.2 Tiziana Life Sciences Plc Business Overview
11.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Products and Services
11.9.4 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
11.9.5 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
11.9.6 Tiziana Life Sciences Plc Recent Development
12 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Dynamics
12.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Industry Trends
12.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Drivers
12.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Challenges
12.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of ND-007
Table 3. Key Players of Foralumab
Table 4. Key Players of Coltelizumab
Table 5. Key Players of AVA-002
Table 6. Key Players of Others
Table 7. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 8. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 9. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 11. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 12. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Players (2018-2023)
Table 14. Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain as of 2024)
Table 15. Ranking of Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Companies by Revenue (US$ Million) in 2024
Table 16. Global 5 Largest Players Market Share by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (CR5 and HHI) & (2018-2023)
Table 17. Global Key Players of T Cell Surface Glycoprotein CD3 Epsilon Chain, Headquarters and Area Served
Table 18. Global Key Players of T Cell Surface Glycoprotein CD3 Epsilon Chain, Product and Application
Table 19. Global Key Players of T Cell Surface Glycoprotein CD3 Epsilon Chain, Date of Enter into This Industry
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2018-2023) & (US$ Million)
Table 22. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2023)
Table 23. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 24. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2024-2034)
Table 25. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2018-2023) & (US$ Million)
Table 26. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2023)
Table 27. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 28. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2024-2034)
Table 29. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023) & (US$ Million)
Table 30. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2023) & (US$ Million)
Table 31. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 32. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2023) & (US$ Million)
Table 33. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 34. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2023) & (US$ Million)
Table 36. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2024-2034) & (US$ Million)
Table 37. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023) & (US$ Million)
Table 38. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2023) & (US$ Million)
Table 39. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 40. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2023) & (US$ Million)
Table 41. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 42. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2023) & (US$ Million)
Table 44. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2024-2034) & (US$ Million)
Table 45. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023) & (US$ Million)
Table 46. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2023) & (US$ Million)
Table 47. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 48. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2023) & (US$ Million)
Table 49. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 50. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 51. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Region (2018-2023) & (US$ Million)
Table 52. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Region (2024-2034) & (US$ Million)
Table 53. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023) & (US$ Million)
Table 54. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2023) & (US$ Million)
Table 55. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 56. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2023) & (US$ Million)
Table 57. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 58. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 59. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2023) & (US$ Million)
Table 60. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2024-2034) & (US$ Million)
Table 61. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Company (2021-2023) & (US$ Million)
Table 62. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2018-2023) & (US$ Million)
Table 63. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2024-2034) & (US$ Million)
Table 64. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application (2024-2034) & (US$ Million)
Table 66. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 67. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2018-2023) & (US$ Million)
Table 68. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Country (2024-2034) & (US$ Million)
Table 69. Amgen Inc Company Details
Table 70. Amgen Inc Business Overview
Table 71. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 72. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 73. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 74. Amgen Inc Recent Development
Table 75. Celgene Corp Company Details
Table 76. Celgene Corp Business Overview
Table 77. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 78. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 79. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 80. Celgene Corp Recent Development
Table 81. F. Hoffmann-La Roche Ltd Company Details
Table 82. F. Hoffmann-La Roche Ltd Business Overview
Table 83. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 84. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 85. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 86. F. Hoffmann-La Roche Ltd Recent Development
Table 87. GlaxoSmithKline Plc Company Details
Table 88. GlaxoSmithKline Plc Business Overview
Table 89. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 90. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 91. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 92. GlaxoSmithKline Plc Recent Development
Table 93. MacroGenics Inc Company Details
Table 94. MacroGenics Inc Business Overview
Table 95. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 96. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 97. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 98. MacroGenics Inc Recent Development
Table 99. Meridigen Biotech Co Ltd Company Details
Table 100. Meridigen Biotech Co Ltd Business Overview
Table 101. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 102. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 103. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 104. Meridigen Biotech Co Ltd Recent Development
Table 105. Numab Innovation AG Company Details
Table 106. Numab Innovation AG Business Overview
Table 107. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 108. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 109. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 110. Numab Innovation AG Recent Development
Table 111. SYNIMMUNE GmbH Company Details
Table 112. SYNIMMUNE GmbH Business Overview
Table 113. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 114. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 115. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 116. SYNIMMUNE GmbH Recent Development
Table 117. Tiziana Life Sciences Plc Company Details
Table 118. Tiziana Life Sciences Plc Business Overview
Table 119. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 120. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023) & (US$ Million)
Table 121. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain SWOT Analysis
Table 122. Tiziana Life Sciences Plc Recent Development
Table 123. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Trends
Table 124. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Drivers
Table 125. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Challenges
Table 126. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Product Picture
Figure 2. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type: 2024 VS 2034
Figure 4. ND-007 Features
Figure 5. Foralumab Features
Figure 6. Coltelizumab Features
Figure 7. AVA-002 Features
Figure 8. Others Features
Figure 9. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 10. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application: 2024 VS 2034
Figure 11. Autoimmune Disorders
Figure 12. Hepatitis B
Figure 13. Multiple Sclerosis
Figure 14. Prostate Cancer
Figure 15. Others
Figure 16. T Cell Surface Glycoprotein CD3 Epsilon Chain Report Years Considered
Figure 17. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size 2018-2034 (US$ Million)
Figure 19. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Market Share by Region: 2024 VS 2034
Figure 20. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Region in 2018 VS 2024
Figure 21. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share Forecast by Region (2024-2034)
Figure 22. Global Top 10 T Cell Surface Glycoprotein CD3 Epsilon Chain Countries Ranking by Market Size (US$ Million) in 2024
Figure 23. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 24. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Players in 2024
Figure 25. Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in 2024
Figure 27. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Company in 2024
Figure 28. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 29. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 30. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Country (2018-2034)
Figure 31. U.S. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 32. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 33. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Company in 2024
Figure 34. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 35. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 36. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Country (2018-2034)
Figure 37. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 38. France T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 39. U.K. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 40. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 41. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 42. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Company in 2024
Figure 43. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 44. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 45. Asia Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Region (2018-2034)
Figure 46. China T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 47. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 48. South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 49. India T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 50. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 51. Taiwan T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 52. Indonesia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 53. Thailand T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 54. Malaysia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 55. Philippines T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 56. Vietnam T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 57. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Company in 2024
Figure 58. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 59. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 60. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Country (2018-2034)
Figure 61. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 62. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 63. Argentina T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 64. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Company in 2024
Figure 65. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2018-2034)
Figure 66. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2018-2034)
Figure 67. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Country (2018-2034)
Figure 68. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 69. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 70. UAE T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2018-2034) & (US$ Million)
Figure 71. Amgen Inc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 72. Celgene Corp Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 73. F. Hoffmann-La Roche Ltd Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 74. GlaxoSmithKline Plc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 75. MacroGenics Inc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 76. Meridigen Biotech Co Ltd Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 77. Numab Innovation AG Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 78. SYNIMMUNE GmbH Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 79. Tiziana Life Sciences Plc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2018-2023)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed